Proprotein Convertase Subtilisin/kexin Type 5 (PCSK5) Peptide
-
- Target See all PCSK5 products
- PCSK5 (Proprotein Convertase Subtilisin/kexin Type 5 (PCSK5))
- Peptide Type
- Synthetic
- Origin
- Mammalian
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Sequence
- CAGAGADGCI NCTEGYFMED GRCVQSCSIS YYFDHSSENG YKSCKKCDIS
- Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of PCSK5 antibody,
Alternative Names: PCSK5 control peptide, PCSK5 antibody Blocking Peptide, Anti-PCSK5 Blocking Peptide, Proprotein Convertase Subtilisin/Kexin Type 5 Blocking Peptide, PC5 Blocking Peptide, PC6 Blocking Peptide, PC6A Blocking Peptide, SPC6 Blocking Peptide, PCSK5, PCSK-5, PCSK 5, PCSK-5 Blocking Peptide, PCSK 5 Blocking Peptide
-
-
- Application Notes
- Optimal conditions should be determined by the investigator
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handling Advice
- Avoid repeated freeze/thaw cycles.
- Storage
- -20 °C
- Storage Comment
- Store at -20 °C long term.
-
- Target
- PCSK5 (Proprotein Convertase Subtilisin/kexin Type 5 (PCSK5))
- Background
- PCSK5 belongs to the subtilisin-like proprotein convertase family. The members of this family are proprotein convertases that process latent precursor proteins into their biologically active products. PCSK5 mediates posttranslational endoproteolytic processing for several integrin alpha subunits. It is thought to process prorenin, pro-membrane type-1 matrix metalloproteinase and HIV-1 glycoprotein gp160. Two alternatively spliced transcripts are described for this gene but only one has its full length nature known.
- Molecular Weight
- 89 kDa
-